PREDICT1: An observational study for identifying blood biomarkers associated with clinical benefit from carboplatin and pemetrexed (CbP) treatment in patients with non-squamous (NS) non-small cell lung cancer (NSCLC) (CJLSG1201).

Tetsunari Hase, Kiyoshi Yanagisawa, Asuki Fukatsu, Tomoki Kimura, Eiji Kojima, Takashi Abe, Kazuyoshi Imaizumi, Yoshitsugu Horio, Tetsuya Oguri, Masashi Yamamoto, Tomohiko Ogasawara, Yasuteru Sugino, Masahiro Morise, Masahiro Nakatochi, Masahiko Ando, Masashi Kondo, Hideo Saka, Hiroshi Saito, Yoshinori Hasegawa, Takashi Takahashi

Journal of Clinical Oncology · 2020

Read source ↗ All evidence

Source type: Peer-reviewed study
DOI: 10.1200/jco.2020.38.15_suppl.9524
Catalogue ID: BFmob79mnx-gbyc2w

Pulse AI · ask about this record

Dig deeper with Pulse AI.

Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.

How does this finding apply in a UK context?→What are the most cited records on this topic?→